Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 119455
Published online Sep 19, 2026. doi: 10.5498/wjp.119455
Published online Sep 19, 2026. doi: 10.5498/wjp.119455
Table 1 Baseline data comparison (nonunion vs healing), n (%)
| Indicators | Nonunion group (n = 17) | Healing group (n = 128) | t/χ2 | P value |
| Age (years) | 58.24 ± 11.14 | 46.29 ± 14.76 | 3.213 | 0.002 |
| Gender | 0.024 | 0.878 | ||
| Male | 12 (70.59) | 88 (68.75) | ||
| Female | 5 (29.41) | 40 (31.25) | ||
| Body mass index (kg/m2) | 25.19 ± 4.10 | 23.70 ± 2.80 | 5.993 | < 0.001 |
| Comorbidity | ||||
| Hypertension | 8 (47.06) | 55 (42.97) | 0.102 | 0.749 |
| Diabetes | 7 (41.18) | 21 (16.41) | 5.909 | 0.015 |
| Atherosclerosis | 5 (29.41) | 20 (15.63) | 1.999 | 0.157 |
| Open fracture | 10 (58.8) | 28 (21.9) | 10.590 | 0.001 |
| Bone defect length (mm) | 51.82 ± 14.43 | 38.44 ± 12.01 | 7.362 | < 0.001 |
| Distraction start time (days) | 12.59 ± 5.81 | 10.20 ± 3.49 | 2.420 | 0.017 |
| Distraction period (days) | 45.24 ± 10.65 | 42.78 ± 9.72 | 0.968 | 0.335 |
| Bone mineralization time (days) | 275.18 ± 102.43 | 191.45 ± 87.24 | 3.639 | 0.004 |
| Depression (PHQ-9) | 16.82 ± 4.25 | 11.28 ± 3.10 | 11.374 | < 0.001 |
| Anxiety (GAD-7) | 15.24 ± 4.12 | 10.51 ± 2.40 | 6.908 | < 0.001 |
| Social support (MSPSS) | 48.53 ± 9.98 | 58.83 ± 10.53 | 3.810 | < 0.001 |
| Current smoker | 9 (52.9) | 35 (27.3) | 4.652 | 0.031 |
| Low-income | 11 (64.7) | 48 (37.5) | 4.603 | 0.032 |
Table 2 Baseline data comparison in the external validation cohort (nonunion vs healing), n (%)
| Indicators | Nonunion group (n = 10) | Healing group (n = 43) | t/χ2 | P value |
| Age (years) | 55.80 ± 15.02 | 47.78 ± 13.57 | 1.654 | 0.104 |
| Gender | 0.024 | 0.876 | ||
| Male | 7 (70.00) | 30 (69.77) | ||
| Female | 3 (30.00) | 13 (33.23) | ||
| Body mass index (kg/m2) | 25.75 ± 3.21 | 24.79 ± 3.12 | 0.867 | 0.390 |
| Comorbidity | ||||
| Hypertension | 5 (50.00) | 18 (69.57) | 0.219 | 0.640 |
| Diabetes | 4 (40.00) | 8 (18.60) | 2.120 | 0.145 |
| Atherosclerosis | 3 (30.00) | 7 (16.28) | 0.998 | 0.318 |
| Open fracture | 6 (60.00) | 9 (20.93) | 6.103 | 0.014 |
| Bone defect length (mm) | 46.90 ± 14.11 | 40.77 ± 12.76 | 1.342 | 0.185 |
| Distraction start time (days) | 10.20 ± 2.82 | 9.35 ± 3.31 | 0.751 | 0.456 |
| Distraction period (days) | 44.80 ± 9.68 | 43.35 ± 8.75 | 0.463 | 0.645 |
| Bone mineralization time (days) | 197.10 ± 110.76 | 211.05 ± 91.30 | 0.418 | 0.678 |
| Depression (PHQ-9) | 16.50 ± 4.12 | 14.60 ± 3.02 | 1.664 | 0.102 |
| Anxiety (GAD-7) | 15.00 ± 3.74 | 12.70 ± 2.41 | 2.438 | 0.018 |
| Social support (MSPSS) | 49.20 ± 9.20 | 62.86 ± 10.07 | 3.922 | < 0.001 |
| Current smoker | 5 (50.00) | 11 (25.58) | 2.442 | 0.118 |
| Low-income | 6 (60.00) | 17 (39.54) | 1.383 | 0.239 |
Table 3 Baseline data comparison (development vs external validation), n (%)
| Development cohort (n = 145) | External validation cohort (n = 53) | t/χ2 | P value | |
| Nonunion | 17 (11.72) | 10 (18.87) | 1.682 | 0.195 |
| Age (years) | 47.69 ± 14.86 | 49.28 ± 14.06 | 0.677 | 0.499 |
| Gender | 0.013 | 0.909 | ||
| Male | 100 (68.97) | 37 (69.81) | ||
| Female | 45 (31.03) | 16 (30.19) | ||
| Body mass index (kg/m2) | 23.87 ± 3.00 | 24.97 ± 3.13 | 2.248 | 0.026 |
| Bone defect length (mm) | 40.01 ± 13.00 | 41.92 ± 13.11 | 0.917 | 0.360 |
| Distraction start time (days) | 10.48 ± 3.88 | 9.51 ± 3.21 | 1.632 | 0.104 |
| Distraction period (days) | 43.07 ± 9.82 | 43.62 ± 8.86 | 0.360 | 0.719 |
| Bone mineralization time (days) | 201.26 ± 92.78 | 208.42 ± 94.27 | 0.479 | 0.633 |
| Open fracture | 38 (26.21) | 15 (28.30) | 0.087 | 0.768 |
| Comorbidity | ||||
| Hypertension | 63 (43.45) | 23 (43.40) | 0.007 | 0.995 |
| Diabetes | 28 (19.31) | 12 (22.64) | 0.267 | 0.605 |
| Atherosclerosis | 25 (17.24) | 10 (18.87) | 0.071 | 0.791 |
| Depression (PHQ-9) | 11.93 ± 3.70 | 14.96 ± 3.30 | 5.249 | 0.000 |
| Anxiety (GAD-7) | 11.06 ± 3.95 | 13.13 ± 2.81 | 4.313 | 0.000 |
| Social support (MSPSS) | 57.62 ± 10.95 | 60.28 ± 11.21 | 1.505 | 0.134 |
| Current smoker | 44 (30.34) | 16 (30.19) | 0.080 | 0.983 |
| Low-income earner | 59 (40.69) | 23 (43.40) | 0.117 | 0.732 |
Table 4 Summary of internal validation model performance indicators for the development cohort
| Traditional clinical model | Integrated model | |
| AUC (95%CI) | 0.854 (0.788-0.919) | 0.923 (0.856-0.990) |
| Sensitivity | 0.588 | 0.882 |
| Specificity | 0.883 | 0.891 |
| Accuracy | 0.849 | 0.890 |
| F1 score | 0.476 | 0.640 |
| DeLong’s test | - | P < 0.05 |
Table 5 Summary of model performance indicators for the external validation cohort
| Traditional clinical model | Integrated model | |
| AUC (95%CI) | 0.823 (0.692-0.954) | 0.888 (0.764-1.000) |
| Sensitivity | 0.200 | 0.400 |
| Specificity | 0.884 | 0.978 |
| Accuracy | 0.750 | 0.867 |
| F1 score | 0.235 | 0.533 |
| DeLong’s test | - | P < 0.05 |
- Citation: Luan FF, Chen JY, Zheng YZ, Hu MH, Huang F, Zheng CX. Efficacy of a machine learning model integrating clinical-psychosocial factors in predicting posttraumatic bone nonunion and bone defects. World J Psychiatry 2026; 16(9): 119455
- URL: https://www.wjgnet.com/2220-3206/full/v16/i9/119455.htm
- DOI: https://dx.doi.org/10.5498/wjp.119455